Bioverge is an investment and engagement platform that aims to connect the world to startup companies transforming healthcare. We’re living at an exciting time - the convergence of biology and technology is rapidly driving the healthcare industry in exciting new directions – making patient care more effective, accessible, personalized, cheaper, and faster. If you could gift the world anything, wouldn't the most impactful be the gift of better health? We believe that there is no more direct and measurable way to make an impact on people's lives than to support the future of this rapidly changing industry. Whether by financial investment or through personal engagement, Bioverge users can directly support the projects that matter most to them… and share in the upside if a company is successful! Bioverge is empowering the patient in all of us to help shape the future of care for us and our loved ones. https://www.bioverge.com https://twitter.com/biovergehq https://angel.co/bioverge/syndicate

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related